Science

Apr 8, 2025, 10:39

Myeloma Paper of the Day, April 8th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: S-MRD<10-5 (sustained MRD two consecutive tests at least 1 year apart) is best PFS predictor and yields best predictive models for risk of MRD resurgence or progression after quad induction + ASCT and fixed duration therapy.”

“Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma”

Authors: Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca Silbermann, Luciano Costa.

More posts featuring Robert Orlowski.

Bhagirathbhai Dholaria Binod Dhakal cancer Eva Medvedova Gayathri Ravi Kelly Godby Luciano Costa multiple myeloma Myeloma Paper of the Day Natalie Callander OncoDaily Oncology Rebecca Silbermann Robert Orlowski Saurabh Chhabra Smith Giri Susan Bal

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

John Cena Announces He Overcame Skin Cancer Twice, Advocates for Sun Safety

William N. Hait to Receive 2025 AACR-Margaret Foti Award for Leadership in Cancer Research

Stella Kyriakides joins ESO as Co-Chair and Senior Lecturer in Cancer Policy to Guide the 2026–2028 Strategic Plan